Valeo Financial Advisors’s Boston Scientific BSX Stock Holding History

Valeo Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,500	Closed	-$134K	–	704
2024 Q4	$134K	Hold	1,500	–	–	﹤0.01%	685
2024 Q3	$126K	Hold	1,500	–	–	﹤0.01%	670
2024 Q2	$116	Sell	1,500 -1,500	-50%	-$110K	﹤0.01%	671
2024 Q1	$218	Hold	3,000	–	–	﹤0.01%	654
2023 Q4	$174	Hold	3,000	–	–	﹤0.01%	645
2023 Q3	$158	Buy	+3,000	New	+$157K	﹤0.01%	631

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Valeo Financial Advisors's BSX Position: Q2 2026 in Review

Valeo Financial Advisors reduced its Boston Scientific (BSX) stake by 16% in Q2 2026, selling an estimated $110K and leaving 10,535 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #477.

Valeo Financial Advisors first reported a position in BSX in Q3 2017 and has held it in 35 quarters since. The position peaked at $2.42M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Valeo Financial Advisors held 10,535 shares of Boston Scientific worth $450K as of Q2 2026.
Valeo Financial Advisors sold 2,030 Boston Scientific shares in Q2 2026, an estimated $110K.
Boston Scientific made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #477 holding.
Valeo Financial Advisors first reported a position in Boston Scientific in Q3 2017 and has held it in 35 quarters since.
Valeo Financial Advisors's Boston Scientific position peaked at $2.42M in Q2 2025.
338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.